nodes	percent_of_prediction	percent_of_DWPC	metapath
Aripiprazole—HTR7—Parkinson's disease	0.131	0.179	CbGaD
Aripiprazole—DRD3—Parkinson's disease	0.123	0.169	CbGaD
Aripiprazole—DRD1—Parkinson's disease	0.121	0.166	CbGaD
Aripiprazole—HTR1A—Parkinson's disease	0.1	0.138	CbGaD
Aripiprazole—DRD2—Parkinson's disease	0.085	0.117	CbGaD
Aripiprazole—HTR2A—Parkinson's disease	0.0657	0.0902	CbGaD
Aripiprazole—CYP2D6—Parkinson's disease	0.0601	0.0825	CbGaD
Aripiprazole—ABCB1—Parkinson's disease	0.0429	0.0589	CbGaD
Aripiprazole—HTR2A—locus ceruleus—Parkinson's disease	0.00143	0.0136	CbGeAlD
Aripiprazole—HTR1B—telencephalic ventricle—Parkinson's disease	0.00141	0.0134	CbGeAlD
Aripiprazole—HTR1D—telencephalic ventricle—Parkinson's disease	0.00137	0.013	CbGeAlD
Aripiprazole—HTR2C—telencephalic ventricle—Parkinson's disease	0.00136	0.0129	CbGeAlD
Aripiprazole—HTR7—pons—Parkinson's disease	0.00133	0.0126	CbGeAlD
Aripiprazole—HTR7—autonomic nervous system—Parkinson's disease	0.00122	0.0116	CbGeAlD
Aripiprazole—HTR2A—cerebellar cortex—Parkinson's disease	0.00117	0.0111	CbGeAlD
Aripiprazole—HTR1A—telencephalic ventricle—Parkinson's disease	0.00114	0.0108	CbGeAlD
Aripiprazole—HTR2A—sympathetic nervous system—Parkinson's disease	0.00113	0.0107	CbGeAlD
Aripiprazole—DRD1—nerve—Parkinson's disease	0.0011	0.0104	CbGeAlD
Aripiprazole—HTR7—telencephalic ventricle—Parkinson's disease	0.00109	0.0103	CbGeAlD
Aripiprazole—HTR3A—nerve—Parkinson's disease	0.00106	0.0101	CbGeAlD
Aripiprazole—DRD2—telencephalic ventricle—Parkinson's disease	0.00103	0.00977	CbGeAlD
Aripiprazole—HTR7—peripheral nervous system—Parkinson's disease	0.000882	0.00836	CbGeAlD
Aripiprazole—HTR2A—pons—Parkinson's disease	0.000827	0.00784	CbGeAlD
Aripiprazole—HTR1E—brainstem—Parkinson's disease	0.000809	0.00767	CbGeAlD
Aripiprazole—HTR1E—forebrain—Parkinson's disease	0.000781	0.0074	CbGeAlD
Aripiprazole—HTR2A—autonomic nervous system—Parkinson's disease	0.000762	0.00722	CbGeAlD
Aripiprazole—HTR7—nerve—Parkinson's disease	0.000688	0.00652	CbGeAlD
Aripiprazole—Vilazodone—HTR1A—Parkinson's disease	0.000687	0.105	CrCbGaD
Aripiprazole—HTR2A—telencephalic ventricle—Parkinson's disease	0.00068	0.00645	CbGeAlD
Aripiprazole—DRD2—nerve—Parkinson's disease	0.00065	0.00616	CbGeAlD
Aripiprazole—ADRA2A—peripheral nervous system—Parkinson's disease	0.000647	0.00613	CbGeAlD
Aripiprazole—HTR6—forebrain—Parkinson's disease	0.000613	0.00581	CbGeAlD
Aripiprazole—SLC6A4—hindbrain—Parkinson's disease	0.000607	0.00575	CbGeAlD
Aripiprazole—DRD5—forebrain—Parkinson's disease	0.000597	0.00565	CbGeAlD
Aripiprazole—Vilazodone—DRD2—Parkinson's disease	0.000583	0.0892	CrCbGaD
Aripiprazole—HTR2A—peripheral nervous system—Parkinson's disease	0.00055	0.00521	CbGeAlD
Aripiprazole—HTR1A—hindbrain—Parkinson's disease	0.000539	0.00511	CbGeAlD
Aripiprazole—H1F0—embryo—Parkinson's disease	0.000522	0.00495	CbGeAlD
Aripiprazole—HTR7—hindbrain—Parkinson's disease	0.000515	0.00488	CbGeAlD
Aripiprazole—ADRA1A—hindbrain—Parkinson's disease	0.000497	0.00471	CbGeAlD
Aripiprazole—DRD2—hindbrain—Parkinson's disease	0.000487	0.00461	CbGeAlD
Aripiprazole—Cilostazol—CYP2D6—Parkinson's disease	0.000485	0.0742	CrCbGaD
Aripiprazole—DRD1—brainstem—Parkinson's disease	0.000472	0.00448	CbGeAlD
Aripiprazole—H1F0—forebrain—Parkinson's disease	0.000462	0.00438	CbGeAlD
Aripiprazole—HTR3A—brainstem—Parkinson's disease	0.000456	0.00432	CbGeAlD
Aripiprazole—DRD1—forebrain—Parkinson's disease	0.000456	0.00432	CbGeAlD
Aripiprazole—HTR1E—head—Parkinson's disease	0.000447	0.00424	CbGeAlD
Aripiprazole—HTR3A—forebrain—Parkinson's disease	0.00044	0.00417	CbGeAlD
Aripiprazole—HTR2A—nerve—Parkinson's disease	0.000429	0.00406	CbGeAlD
Aripiprazole—HTR1E—nervous system—Parkinson's disease	0.000424	0.00402	CbGeAlD
Aripiprazole—Vilazodone—CYP2D6—Parkinson's disease	0.000412	0.0631	CrCbGaD
Aripiprazole—HTR1E—central nervous system—Parkinson's disease	0.000408	0.00387	CbGeAlD
Aripiprazole—CHRM4—head—Parkinson's disease	0.000392	0.00372	CbGeAlD
Aripiprazole—H1F0—cardiovascular system—Parkinson's disease	0.00039	0.0037	CbGeAlD
Aripiprazole—HTR1B—brainstem—Parkinson's disease	0.000383	0.00363	CbGeAlD
Aripiprazole—DRD4—brain—Parkinson's disease	0.000376	0.00356	CbGeAlD
Aripiprazole—CHRM4—nervous system—Parkinson's disease	0.000372	0.00352	CbGeAlD
Aripiprazole—HTR1D—brainstem—Parkinson's disease	0.000371	0.00351	CbGeAlD
Aripiprazole—HTR1B—forebrain—Parkinson's disease	0.000369	0.0035	CbGeAlD
Aripiprazole—CHRM2—forebrain—Parkinson's disease	0.000367	0.00348	CbGeAlD
Aripiprazole—HTR2C—brainstem—Parkinson's disease	0.000367	0.00348	CbGeAlD
Aripiprazole—DRD3—head—Parkinson's disease	0.000365	0.00345	CbGeAlD
Aripiprazole—CHRM4—central nervous system—Parkinson's disease	0.000358	0.00339	CbGeAlD
Aripiprazole—HTR1D—forebrain—Parkinson's disease	0.000358	0.00339	CbGeAlD
Aripiprazole—HTR2C—forebrain—Parkinson's disease	0.000354	0.00336	CbGeAlD
Aripiprazole—HTR6—head—Parkinson's disease	0.000351	0.00333	CbGeAlD
Aripiprazole—SLC6A4—brainstem—Parkinson's disease	0.000348	0.0033	CbGeAlD
Aripiprazole—ADRB1—forebrain—Parkinson's disease	0.000348	0.00329	CbGeAlD
Aripiprazole—DRD3—nervous system—Parkinson's disease	0.000346	0.00328	CbGeAlD
Aripiprazole—DRD5—head—Parkinson's disease	0.000342	0.00324	CbGeAlD
Aripiprazole—Ziprasidone—HTR7—Parkinson's disease	0.000339	0.0519	CrCbGaD
Aripiprazole—SLC6A4—forebrain—Parkinson's disease	0.000336	0.00318	CbGeAlD
Aripiprazole—CHRM1—forebrain—Parkinson's disease	0.000334	0.00317	CbGeAlD
Aripiprazole—H1F0—medulla oblongata—Parkinson's disease	0.000334	0.00316	CbGeAlD
Aripiprazole—DRD3—central nervous system—Parkinson's disease	0.000333	0.00315	CbGeAlD
Aripiprazole—HTR6—nervous system—Parkinson's disease	0.000333	0.00315	CbGeAlD
Aripiprazole—HTR2B—forebrain—Parkinson's disease	0.000333	0.00315	CbGeAlD
Aripiprazole—HTR1E—brain—Parkinson's disease	0.000324	0.00307	CbGeAlD
Aripiprazole—DRD5—nervous system—Parkinson's disease	0.000324	0.00307	CbGeAlD
Aripiprazole—HTR2A—hindbrain—Parkinson's disease	0.000321	0.00304	CbGeAlD
Aripiprazole—HTR6—central nervous system—Parkinson's disease	0.00032	0.00304	CbGeAlD
Aripiprazole—Ziprasidone—DRD3—Parkinson's disease	0.000319	0.0488	CrCbGaD
Aripiprazole—Ziprasidone—DRD1—Parkinson's disease	0.000313	0.0479	CrCbGaD
Aripiprazole—HTR1B—cardiovascular system—Parkinson's disease	0.000312	0.00296	CbGeAlD
Aripiprazole—DRD5—central nervous system—Parkinson's disease	0.000312	0.00296	CbGeAlD
Aripiprazole—CHRM2—cardiovascular system—Parkinson's disease	0.000311	0.00294	CbGeAlD
Aripiprazole—HTR1A—brainstem—Parkinson's disease	0.000309	0.00293	CbGeAlD
Aripiprazole—CHRM5—head—Parkinson's disease	0.000307	0.0029	CbGeAlD
Aripiprazole—H1F0—midbrain—Parkinson's disease	0.000305	0.00289	CbGeAlD
Aripiprazole—HTR1D—cardiovascular system—Parkinson's disease	0.000302	0.00287	CbGeAlD
Aripiprazole—DRD1—midbrain—Parkinson's disease	0.000301	0.00285	CbGeAlD
Aripiprazole—CHRM3—forebrain—Parkinson's disease	0.000299	0.00284	CbGeAlD
Aripiprazole—HTR1A—forebrain—Parkinson's disease	0.000298	0.00283	CbGeAlD
Aripiprazole—H1F0—spinal cord—Parkinson's disease	0.000297	0.00282	CbGeAlD
Aripiprazole—HTR7—brainstem—Parkinson's disease	0.000295	0.0028	CbGeAlD
Aripiprazole—ADRB1—cardiovascular system—Parkinson's disease	0.000294	0.00278	CbGeAlD
Aripiprazole—CYP2D6—hindbrain—Parkinson's disease	0.000293	0.00277	CbGeAlD
Aripiprazole—CHRM5—nervous system—Parkinson's disease	0.000291	0.00275	CbGeAlD
Aripiprazole—HTR7—forebrain—Parkinson's disease	0.000285	0.0027	CbGeAlD
Aripiprazole—ADRA1A—brainstem—Parkinson's disease	0.000285	0.0027	CbGeAlD
Aripiprazole—CHRM4—brain—Parkinson's disease	0.000284	0.00269	CbGeAlD
Aripiprazole—CHRM1—cardiovascular system—Parkinson's disease	0.000283	0.00268	CbGeAlD
Aripiprazole—HTR2B—cardiovascular system—Parkinson's disease	0.000281	0.00267	CbGeAlD
Aripiprazole—ADRA1B—head—Parkinson's disease	0.00028	0.00265	CbGeAlD
Aripiprazole—CHRM5—central nervous system—Parkinson's disease	0.00028	0.00265	CbGeAlD
Aripiprazole—DRD2—brainstem—Parkinson's disease	0.000279	0.00264	CbGeAlD
Aripiprazole—ADRA1A—forebrain—Parkinson's disease	0.000275	0.0026	CbGeAlD
Aripiprazole—DRD2—forebrain—Parkinson's disease	0.000269	0.00255	CbGeAlD
Aripiprazole—ADRA1B—nervous system—Parkinson's disease	0.000266	0.00252	CbGeAlD
Aripiprazole—KCNH2—forebrain—Parkinson's disease	0.000265	0.00252	CbGeAlD
Aripiprazole—H1F0—head—Parkinson's disease	0.000264	0.00251	CbGeAlD
Aripiprazole—DRD3—brain—Parkinson's disease	0.000264	0.0025	CbGeAlD
Aripiprazole—DRD1—head—Parkinson's disease	0.000261	0.00247	CbGeAlD
Aripiprazole—Ziprasidone—HTR1A—Parkinson's disease	0.00026	0.0398	CrCbGaD
Aripiprazole—HTR2C—medulla oblongata—Parkinson's disease	0.000256	0.00242	CbGeAlD
Aripiprazole—ADRA1B—central nervous system—Parkinson's disease	0.000256	0.00242	CbGeAlD
Aripiprazole—HTR6—brain—Parkinson's disease	0.000254	0.00241	CbGeAlD
Aripiprazole—HTR3A—head—Parkinson's disease	0.000252	0.00239	CbGeAlD
Aripiprazole—HTR1A—cardiovascular system—Parkinson's disease	0.000252	0.00239	CbGeAlD
Aripiprazole—H1F0—nervous system—Parkinson's disease	0.000251	0.00238	CbGeAlD
Aripiprazole—Nefazodone—SLC6A3—Parkinson's disease	0.00025	0.0382	CrCbGaD
Aripiprazole—DRD5—brain—Parkinson's disease	0.000248	0.00235	CbGeAlD
Aripiprazole—DRD1—nervous system—Parkinson's disease	0.000248	0.00235	CbGeAlD
Aripiprazole—HTR1B—midbrain—Parkinson's disease	0.000244	0.00231	CbGeAlD
Aripiprazole—H1F0—central nervous system—Parkinson's disease	0.000241	0.00229	CbGeAlD
Aripiprazole—HTR7—cardiovascular system—Parkinson's disease	0.000241	0.00228	CbGeAlD
Aripiprazole—HTR3A—nervous system—Parkinson's disease	0.000239	0.00227	CbGeAlD
Aripiprazole—DRD1—central nervous system—Parkinson's disease	0.000238	0.00226	CbGeAlD
Aripiprazole—HTR1B—spinal cord—Parkinson's disease	0.000238	0.00226	CbGeAlD
Aripiprazole—HTR1D—midbrain—Parkinson's disease	0.000236	0.00224	CbGeAlD
Aripiprazole—H1F0—cerebellum—Parkinson's disease	0.000236	0.00224	CbGeAlD
Aripiprazole—HTR2C—midbrain—Parkinson's disease	0.000234	0.00222	CbGeAlD
Aripiprazole—ADRA1A—cardiovascular system—Parkinson's disease	0.000232	0.0022	CbGeAlD
Aripiprazole—HTR3A—central nervous system—Parkinson's disease	0.00023	0.00218	CbGeAlD
Aripiprazole—HTR2C—spinal cord—Parkinson's disease	0.000228	0.00216	CbGeAlD
Aripiprazole—KCNH2—cardiovascular system—Parkinson's disease	0.000224	0.00213	CbGeAlD
Aripiprazole—Prochlorperazine—DRD3—Parkinson's disease	0.000222	0.034	CrCbGaD
Aripiprazole—CHRM5—brain—Parkinson's disease	0.000222	0.0021	CbGeAlD
Aripiprazole—SLC6A4—midbrain—Parkinson's disease	0.000222	0.0021	CbGeAlD
Aripiprazole—Ziprasidone—DRD2—Parkinson's disease	0.000221	0.0338	CrCbGaD
Aripiprazole—Nefazodone—HTR1A—Parkinson's disease	0.000219	0.0335	CrCbGaD
Aripiprazole—SLC6A4—spinal cord—Parkinson's disease	0.000216	0.00205	CbGeAlD
Aripiprazole—HRH1—forebrain—Parkinson's disease	0.000213	0.00202	CbGeAlD
Aripiprazole—HTR1B—head—Parkinson's disease	0.000212	0.002	CbGeAlD
Aripiprazole—CHRM2—head—Parkinson's disease	0.00021	0.00199	CbGeAlD
Aripiprazole—ADRA2A—forebrain—Parkinson's disease	0.000209	0.00198	CbGeAlD
Aripiprazole—HTR7—medulla oblongata—Parkinson's disease	0.000206	0.00195	CbGeAlD
Aripiprazole—HTR1D—head—Parkinson's disease	0.000205	0.00194	CbGeAlD
Aripiprazole—ADRA1B—brain—Parkinson's disease	0.000203	0.00192	CbGeAlD
Aripiprazole—HTR2C—head—Parkinson's disease	0.000203	0.00192	CbGeAlD
Aripiprazole—Trazodone—HTR1A—Parkinson's disease	0.000202	0.031	CrCbGaD
Aripiprazole—HTR2A—embryo—Parkinson's disease	0.000201	0.0019	CbGeAlD
Aripiprazole—HTR1B—nervous system—Parkinson's disease	0.000201	0.0019	CbGeAlD
Aripiprazole—CHRM2—nervous system—Parkinson's disease	0.000199	0.00189	CbGeAlD
Aripiprazole—ADRB1—head—Parkinson's disease	0.000199	0.00189	CbGeAlD
Aripiprazole—HTR1A—midbrain—Parkinson's disease	0.000197	0.00187	CbGeAlD
Aripiprazole—HTR1D—nervous system—Parkinson's disease	0.000194	0.00184	CbGeAlD
Aripiprazole—HTR1B—central nervous system—Parkinson's disease	0.000193	0.00183	CbGeAlD
Aripiprazole—HTR2C—nervous system—Parkinson's disease	0.000192	0.00182	CbGeAlD
Aripiprazole—SLC6A4—head—Parkinson's disease	0.000192	0.00182	CbGeAlD
Aripiprazole—HTR1A—spinal cord—Parkinson's disease	0.000192	0.00182	CbGeAlD
Aripiprazole—CHRM2—central nervous system—Parkinson's disease	0.000192	0.00182	CbGeAlD
Aripiprazole—KCNH2—medulla oblongata—Parkinson's disease	0.000192	0.00182	CbGeAlD
Aripiprazole—H1F0—brain—Parkinson's disease	0.000192	0.00182	CbGeAlD
Aripiprazole—CHRM1—head—Parkinson's disease	0.000192	0.00181	CbGeAlD
Aripiprazole—HTR2B—head—Parkinson's disease	0.000191	0.00181	CbGeAlD
Aripiprazole—ADRA2C—medulla oblongata—Parkinson's disease	0.000189	0.00179	CbGeAlD
Aripiprazole—DRD1—brain—Parkinson's disease	0.000189	0.00179	CbGeAlD
Aripiprazole—ADRB1—nervous system—Parkinson's disease	0.000189	0.00179	CbGeAlD
Aripiprazole—HTR7—midbrain—Parkinson's disease	0.000188	0.00178	CbGeAlD
Aripiprazole—HTR1D—central nervous system—Parkinson's disease	0.000187	0.00177	CbGeAlD
Aripiprazole—HTR2C—central nervous system—Parkinson's disease	0.000185	0.00175	CbGeAlD
Aripiprazole—HTR2A—brainstem—Parkinson's disease	0.000184	0.00174	CbGeAlD
Aripiprazole—HTR7—spinal cord—Parkinson's disease	0.000184	0.00174	CbGeAlD
Aripiprazole—HTR3A—brain—Parkinson's disease	0.000183	0.00173	CbGeAlD
Aripiprazole—SLC6A4—nervous system—Parkinson's disease	0.000182	0.00173	CbGeAlD
Aripiprazole—ADRB1—central nervous system—Parkinson's disease	0.000182	0.00172	CbGeAlD
Aripiprazole—CHRM1—nervous system—Parkinson's disease	0.000182	0.00172	CbGeAlD
Aripiprazole—HTR2B—nervous system—Parkinson's disease	0.000181	0.00171	CbGeAlD
Aripiprazole—DRD2—midbrain—Parkinson's disease	0.000178	0.00169	CbGeAlD
Aripiprazole—HTR2A—forebrain—Parkinson's disease	0.000178	0.00168	CbGeAlD
Aripiprazole—SLC6A4—central nervous system—Parkinson's disease	0.000175	0.00166	CbGeAlD
Aripiprazole—KCNH2—midbrain—Parkinson's disease	0.000175	0.00166	CbGeAlD
Aripiprazole—CHRM1—central nervous system—Parkinson's disease	0.000175	0.00166	CbGeAlD
Aripiprazole—HTR2B—central nervous system—Parkinson's disease	0.000174	0.00165	CbGeAlD
Aripiprazole—ADRA2C—midbrain—Parkinson's disease	0.000173	0.00164	CbGeAlD
Aripiprazole—CHRM3—head—Parkinson's disease	0.000171	0.00162	CbGeAlD
Aripiprazole—KCNH2—spinal cord—Parkinson's disease	0.000171	0.00162	CbGeAlD
Aripiprazole—HTR1A—head—Parkinson's disease	0.000171	0.00162	CbGeAlD
Aripiprazole—Ziprasidone—HTR2A—Parkinson's disease	0.000171	0.0261	CrCbGaD
Aripiprazole—Perphenazine—HTR7—Parkinson's disease	0.000169	0.0259	CrCbGaD
Aripiprazole—ADRA2C—spinal cord—Parkinson's disease	0.000169	0.0016	CbGeAlD
Aripiprazole—CYP2D6—brainstem—Parkinson's disease	0.000168	0.00159	CbGeAlD
Aripiprazole—HTR7—head—Parkinson's disease	0.000163	0.00155	CbGeAlD
Aripiprazole—CHRM3—nervous system—Parkinson's disease	0.000162	0.00154	CbGeAlD
Aripiprazole—CYP2D6—forebrain—Parkinson's disease	0.000162	0.00153	CbGeAlD
Aripiprazole—HTR1A—nervous system—Parkinson's disease	0.000162	0.00153	CbGeAlD
Aripiprazole—ADRA1A—head—Parkinson's disease	0.000157	0.00149	CbGeAlD
Aripiprazole—CHRM3—central nervous system—Parkinson's disease	0.000156	0.00148	CbGeAlD
Aripiprazole—Ziprasidone—CYP2D6—Parkinson's disease	0.000156	0.0239	CrCbGaD
Aripiprazole—Perphenazine—DRD1—Parkinson's disease	0.000156	0.0239	CrCbGaD
Aripiprazole—HTR1A—central nervous system—Parkinson's disease	0.000156	0.00148	CbGeAlD
Aripiprazole—HTR7—nervous system—Parkinson's disease	0.000155	0.00147	CbGeAlD
Aripiprazole—DRD2—head—Parkinson's disease	0.000154	0.00146	CbGeAlD
Aripiprazole—Prochlorperazine—DRD2—Parkinson's disease	0.000154	0.0235	CrCbGaD
Aripiprazole—HTR1B—brain—Parkinson's disease	0.000153	0.00145	CbGeAlD
Aripiprazole—CHRM2—brain—Parkinson's disease	0.000152	0.00144	CbGeAlD
Aripiprazole—HTR1A—cerebellum—Parkinson's disease	0.000152	0.00144	CbGeAlD
Aripiprazole—KCNH2—head—Parkinson's disease	0.000152	0.00144	CbGeAlD
Aripiprazole—ADRA2A—medulla oblongata—Parkinson's disease	0.000151	0.00143	CbGeAlD
Aripiprazole—HTR2A—cardiovascular system—Parkinson's disease	0.00015	0.00142	CbGeAlD
Aripiprazole—ADRA2C—head—Parkinson's disease	0.00015	0.00142	CbGeAlD
Aripiprazole—ADRA1A—nervous system—Parkinson's disease	0.000149	0.00141	CbGeAlD
Aripiprazole—HTR7—central nervous system—Parkinson's disease	0.000149	0.00141	CbGeAlD
Aripiprazole—HTR1D—brain—Parkinson's disease	0.000148	0.00141	CbGeAlD
Aripiprazole—HTR2C—brain—Parkinson's disease	0.000147	0.00139	CbGeAlD
Aripiprazole—DRD2—nervous system—Parkinson's disease	0.000146	0.00139	CbGeAlD
Aripiprazole—HTR7—cerebellum—Parkinson's disease	0.000146	0.00138	CbGeAlD
Aripiprazole—ADRB1—brain—Parkinson's disease	0.000144	0.00137	CbGeAlD
Aripiprazole—KCNH2—nervous system—Parkinson's disease	0.000144	0.00137	CbGeAlD
Aripiprazole—ADRA1A—central nervous system—Parkinson's disease	0.000144	0.00136	CbGeAlD
Aripiprazole—Nefazodone—HTR2A—Parkinson's disease	0.000143	0.0219	CrCbGaD
Aripiprazole—ADRA2C—nervous system—Parkinson's disease	0.000142	0.00135	CbGeAlD
Aripiprazole—DRD2—central nervous system—Parkinson's disease	0.000141	0.00133	CbGeAlD
Aripiprazole—ADRA1A—cerebellum—Parkinson's disease	0.00014	0.00133	CbGeAlD
Aripiprazole—SLC6A4—brain—Parkinson's disease	0.000139	0.00132	CbGeAlD
Aripiprazole—CHRM1—brain—Parkinson's disease	0.000139	0.00132	CbGeAlD
Aripiprazole—KCNH2—central nervous system—Parkinson's disease	0.000139	0.00131	CbGeAlD
Aripiprazole—HTR2B—brain—Parkinson's disease	0.000138	0.00131	CbGeAlD
Aripiprazole—ADRA2A—midbrain—Parkinson's disease	0.000138	0.00131	CbGeAlD
Aripiprazole—DRD2—cerebellum—Parkinson's disease	0.000138	0.0013	CbGeAlD
Aripiprazole—ADRA2C—central nervous system—Parkinson's disease	0.000137	0.0013	CbGeAlD
Aripiprazole—KCNH2—cerebellum—Parkinson's disease	0.000136	0.00128	CbGeAlD
Aripiprazole—ADRA2A—spinal cord—Parkinson's disease	0.000135	0.00128	CbGeAlD
Aripiprazole—ADRA2C—cerebellum—Parkinson's disease	0.000134	0.00127	CbGeAlD
Aripiprazole—Trazodone—HTR2A—Parkinson's disease	0.000133	0.0203	CrCbGaD
Aripiprazole—ABCB1—embryo—Parkinson's disease	0.000132	0.00125	CbGeAlD
Aripiprazole—Nefazodone—CYP2D6—Parkinson's disease	0.000131	0.0201	CrCbGaD
Aripiprazole—Perphenazine—HTR1A—Parkinson's disease	0.00013	0.0198	CrCbGaD
Aripiprazole—HTR2A—medulla oblongata—Parkinson's disease	0.000128	0.00122	CbGeAlD
Aripiprazole—CHRM3—brain—Parkinson's disease	0.000124	0.00118	CbGeAlD
Aripiprazole—HTR1A—brain—Parkinson's disease	0.000124	0.00117	CbGeAlD
Aripiprazole—HRH1—head—Parkinson's disease	0.000122	0.00115	CbGeAlD
Aripiprazole—Trazodone—CYP2D6—Parkinson's disease	0.000121	0.0186	CrCbGaD
Aripiprazole—ADRA2A—head—Parkinson's disease	0.00012	0.00113	CbGeAlD
Aripiprazole—HTR7—brain—Parkinson's disease	0.000118	0.00112	CbGeAlD
Aripiprazole—HTR2A—midbrain—Parkinson's disease	0.000117	0.00111	CbGeAlD
Aripiprazole—ABCB1—forebrain—Parkinson's disease	0.000116	0.0011	CbGeAlD
Aripiprazole—HRH1—nervous system—Parkinson's disease	0.000115	0.00109	CbGeAlD
Aripiprazole—HTR2A—spinal cord—Parkinson's disease	0.000114	0.00108	CbGeAlD
Aripiprazole—ADRA1A—brain—Parkinson's disease	0.000114	0.00108	CbGeAlD
Aripiprazole—ADRA2A—nervous system—Parkinson's disease	0.000113	0.00107	CbGeAlD
Aripiprazole—DRD2—brain—Parkinson's disease	0.000112	0.00106	CbGeAlD
Aripiprazole—HRH1—central nervous system—Parkinson's disease	0.000111	0.00105	CbGeAlD
Aripiprazole—KCNH2—brain—Parkinson's disease	0.00011	0.00104	CbGeAlD
Aripiprazole—Perphenazine—DRD2—Parkinson's disease	0.00011	0.0168	CrCbGaD
Aripiprazole—ADRA2A—central nervous system—Parkinson's disease	0.000109	0.00103	CbGeAlD
Aripiprazole—Prochlorperazine—CYP2D6—Parkinson's disease	0.000109	0.0166	CrCbGaD
Aripiprazole—ADRA2C—brain—Parkinson's disease	0.000109	0.00103	CbGeAlD
Aripiprazole—ADRA2A—cerebellum—Parkinson's disease	0.000107	0.00101	CbGeAlD
Aripiprazole—HTR2A—head—Parkinson's disease	0.000102	0.000964	CbGeAlD
Aripiprazole—ABCB1—cardiovascular system—Parkinson's disease	9.84e-05	0.000933	CbGeAlD
Aripiprazole—HTR2A—nervous system—Parkinson's disease	9.65e-05	0.000914	CbGeAlD
Aripiprazole—Nefazodone—ABCB1—Parkinson's disease	9.37e-05	0.0143	CrCbGaD
Aripiprazole—HTR2A—central nervous system—Parkinson's disease	9.29e-05	0.00088	CbGeAlD
Aripiprazole—CYP2D6—head—Parkinson's disease	9.27e-05	0.000878	CbGeAlD
Aripiprazole—HTR2A—cerebellum—Parkinson's disease	9.08e-05	0.00086	CbGeAlD
Aripiprazole—CYP3A4—nervous system—Parkinson's disease	8.93e-05	0.000846	CbGeAlD
Aripiprazole—HRH1—brain—Parkinson's disease	8.83e-05	0.000836	CbGeAlD
Aripiprazole—CYP2D6—nervous system—Parkinson's disease	8.79e-05	0.000833	CbGeAlD
Aripiprazole—ADRA2A—brain—Parkinson's disease	8.67e-05	0.000822	CbGeAlD
Aripiprazole—Trazodone—ABCB1—Parkinson's disease	8.67e-05	0.0133	CrCbGaD
Aripiprazole—CYP3A4—central nervous system—Parkinson's disease	8.6e-05	0.000815	CbGeAlD
Aripiprazole—Perphenazine—HTR2A—Parkinson's disease	8.5e-05	0.013	CrCbGaD
Aripiprazole—CYP2D6—central nervous system—Parkinson's disease	8.46e-05	0.000802	CbGeAlD
Aripiprazole—ABCB1—medulla oblongata—Parkinson's disease	8.41e-05	0.000797	CbGeAlD
Aripiprazole—CYP2D6—cerebellum—Parkinson's disease	8.27e-05	0.000784	CbGeAlD
Aripiprazole—Perphenazine—CYP2D6—Parkinson's disease	7.77e-05	0.0119	CrCbGaD
Aripiprazole—ABCB1—midbrain—Parkinson's disease	7.69e-05	0.000729	CbGeAlD
Aripiprazole—ABCB1—spinal cord—Parkinson's disease	7.5e-05	0.000711	CbGeAlD
Aripiprazole—HTR2A—brain—Parkinson's disease	7.37e-05	0.000699	CbGeAlD
Aripiprazole—CYP2D6—brain—Parkinson's disease	6.72e-05	0.000636	CbGeAlD
Aripiprazole—ABCB1—head—Parkinson's disease	6.67e-05	0.000632	CbGeAlD
Aripiprazole—ABCB1—nervous system—Parkinson's disease	6.32e-05	0.000599	CbGeAlD
Aripiprazole—ABCB1—central nervous system—Parkinson's disease	6.09e-05	0.000577	CbGeAlD
Aripiprazole—ABCB1—cerebellum—Parkinson's disease	5.95e-05	0.000564	CbGeAlD
Aripiprazole—ABCB1—brain—Parkinson's disease	4.83e-05	0.000458	CbGeAlD
Aripiprazole—DRD2—Signaling Pathways—IGF2—Parkinson's disease	3.76e-06	2.35e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—NGF—Parkinson's disease	3.76e-06	2.35e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—HTR2A—Parkinson's disease	3.75e-06	2.34e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—NGF—Parkinson's disease	3.75e-06	2.34e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—HMOX1—Parkinson's disease	3.74e-06	2.34e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—DDC—Parkinson's disease	3.74e-06	2.34e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—INS—Parkinson's disease	3.74e-06	2.33e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—CTGF—Parkinson's disease	3.73e-06	2.33e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—HTR2A—Parkinson's disease	3.71e-06	2.32e-05	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—CASP3—Parkinson's disease	3.71e-06	2.32e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—IGF2—Parkinson's disease	3.7e-06	2.31e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—IGF2—Parkinson's disease	3.7e-06	2.31e-05	CbGpPWpGaD
Aripiprazole—DRD5—Signaling by GPCR—IL6—Parkinson's disease	3.69e-06	2.3e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—IGF2—Parkinson's disease	3.68e-06	2.3e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—INS—Parkinson's disease	3.68e-06	2.3e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—IGF2—Parkinson's disease	3.67e-06	2.29e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—MTHFR—Parkinson's disease	3.67e-06	2.29e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—GPX1—Parkinson's disease	3.65e-06	2.28e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—NGF—Parkinson's disease	3.64e-06	2.27e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—IGF1R—Parkinson's disease	3.64e-06	2.27e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—IGF2—Parkinson's disease	3.64e-06	2.27e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—IGF2—Parkinson's disease	3.63e-06	2.27e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—INS—Parkinson's disease	3.63e-06	2.27e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—EDN1—Parkinson's disease	3.6e-06	2.25e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—ABCB1—Parkinson's disease	3.59e-06	2.24e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—NGF—Parkinson's disease	3.59e-06	2.24e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—HTR2A—Parkinson's disease	3.58e-06	2.24e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—IGF1R—Parkinson's disease	3.58e-06	2.24e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—IGF1R—Parkinson's disease	3.57e-06	2.23e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—HTR2A—Parkinson's disease	3.57e-06	2.23e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—IGF1R—Parkinson's disease	3.56e-06	2.22e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—IGF1R—Parkinson's disease	3.55e-06	2.22e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—EDN1—Parkinson's disease	3.54e-06	2.21e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GSTA4—Parkinson's disease	3.53e-06	2.21e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—EDN1—Parkinson's disease	3.53e-06	2.21e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—EDN1—Parkinson's disease	3.52e-06	2.2e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—IGF1R—Parkinson's disease	3.52e-06	2.2e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—CTGF—Parkinson's disease	3.51e-06	2.19e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—INS—Parkinson's disease	3.51e-06	2.19e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—EDN1—Parkinson's disease	3.51e-06	2.19e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—IGF1R—Parkinson's disease	3.51e-06	2.19e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—GSTM1—Parkinson's disease	3.49e-06	2.18e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—APOE—Parkinson's disease	3.48e-06	2.18e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—EDN1—Parkinson's disease	3.48e-06	2.17e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—INS—Parkinson's disease	3.47e-06	2.17e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—CYP2E1—Parkinson's disease	3.47e-06	2.17e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—HTR2A—Parkinson's disease	3.47e-06	2.17e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—EDN1—Parkinson's disease	3.47e-06	2.16e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—APOE—Parkinson's disease	3.45e-06	2.16e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—NQO1—Parkinson's disease	3.43e-06	2.14e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—HTR2A—Parkinson's disease	3.41e-06	2.13e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—APOE—Parkinson's disease	3.41e-06	2.13e-05	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—MAPK8—Parkinson's disease	3.41e-06	2.13e-05	CbGpPWpGaD
Aripiprazole—CYP3A7—Metabolism—INS—Parkinson's disease	3.39e-06	2.12e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—TH—Parkinson's disease	3.38e-06	2.11e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IGF2—Parkinson's disease	3.37e-06	2.1e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—MTHFR—Parkinson's disease	3.36e-06	2.1e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—GPX1—Parkinson's disease	3.34e-06	2.09e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—APOE—Parkinson's disease	3.33e-06	2.08e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—APOE—Parkinson's disease	3.31e-06	2.07e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—INS—Parkinson's disease	3.31e-06	2.07e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—NGF—Parkinson's disease	3.31e-06	2.06e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—INS—Parkinson's disease	3.29e-06	2.06e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	3.27e-06	2.04e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—INS—Parkinson's disease	3.27e-06	2.04e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IGF1R—Parkinson's disease	3.26e-06	2.03e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—NGF—Parkinson's disease	3.25e-06	2.03e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—CYCS—Parkinson's disease	3.25e-06	2.03e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—NGF—Parkinson's disease	3.25e-06	2.03e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—NQO1—Parkinson's disease	3.24e-06	2.02e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—NGF—Parkinson's disease	3.23e-06	2.02e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—NGF—Parkinson's disease	3.22e-06	2.01e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—APOE—Parkinson's disease	3.22e-06	2.01e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—EDN1—Parkinson's disease	3.22e-06	2.01e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—NGF—Parkinson's disease	3.19e-06	1.99e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—TH—Parkinson's disease	3.19e-06	1.99e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—NGF—Parkinson's disease	3.18e-06	1.99e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	3.18e-06	1.99e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—APOE—Parkinson's disease	3.17e-06	1.98e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—MAOB—Parkinson's disease	3.15e-06	1.97e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—HTR2A—Parkinson's disease	3.15e-06	1.96e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—APOE—Parkinson's disease	3.13e-06	1.96e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—HTR2A—Parkinson's disease	3.09e-06	1.93e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—MTHFR—Parkinson's disease	3.08e-06	1.93e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—HTR2A—Parkinson's disease	3.08e-06	1.92e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—HTR2A—Parkinson's disease	3.07e-06	1.92e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—CYCS—Parkinson's disease	3.06e-06	1.91e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—HTR2A—Parkinson's disease	3.04e-06	1.9e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—HTR2A—Parkinson's disease	3.03e-06	1.89e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—INS—Parkinson's disease	2.98e-06	1.86e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—NGF—Parkinson's disease	2.96e-06	1.85e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—INS—Parkinson's disease	2.95e-06	1.84e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—APOE—Parkinson's disease	2.93e-06	1.83e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—INS—Parkinson's disease	2.92e-06	1.82e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—APOE—Parkinson's disease	2.88e-06	1.8e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—COMT—Parkinson's disease	2.88e-06	1.8e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—APOE—Parkinson's disease	2.87e-06	1.79e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—APOE—Parkinson's disease	2.87e-06	1.79e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—GSTP1—Parkinson's disease	2.86e-06	1.79e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—APOE—Parkinson's disease	2.86e-06	1.79e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—CASP3—Parkinson's disease	2.86e-06	1.79e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—CASP3—Parkinson's disease	2.86e-06	1.79e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—MAOA—Parkinson's disease	2.86e-06	1.78e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—APOE—Parkinson's disease	2.85e-06	1.78e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—INS—Parkinson's disease	2.85e-06	1.78e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling by GPCR—IL6—Parkinson's disease	2.84e-06	1.78e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling by GPCR—IL6—Parkinson's disease	2.84e-06	1.77e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—CASP3—Parkinson's disease	2.84e-06	1.77e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—INS—Parkinson's disease	2.83e-06	1.77e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—APOE—Parkinson's disease	2.83e-06	1.76e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—HMOX1—Parkinson's disease	2.82e-06	1.76e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling by GPCR—IL6—Parkinson's disease	2.82e-06	1.76e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—APOE—Parkinson's disease	2.82e-06	1.76e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—HTR2A—Parkinson's disease	2.82e-06	1.76e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—CASP3—Parkinson's disease	2.78e-06	1.74e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling by GPCR—IL6—Parkinson's disease	2.76e-06	1.73e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—INS—Parkinson's disease	2.75e-06	1.72e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—CASP3—Parkinson's disease	2.74e-06	1.71e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling by GPCR—IL6—Parkinson's disease	2.72e-06	1.7e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—COMT—Parkinson's disease	2.71e-06	1.69e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—INS—Parkinson's disease	2.71e-06	1.69e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—CASP3—Parkinson's disease	2.7e-06	1.69e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—GSTP1—Parkinson's disease	2.7e-06	1.69e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—MAOA—Parkinson's disease	2.69e-06	1.68e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling by GPCR—IL6—Parkinson's disease	2.68e-06	1.68e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—INS—Parkinson's disease	2.68e-06	1.67e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—HMOX1—Parkinson's disease	2.66e-06	1.66e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—GSTM1—Parkinson's disease	2.63e-06	1.64e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—MAPK8—Parkinson's disease	2.63e-06	1.64e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—MAPK8—Parkinson's disease	2.63e-06	1.64e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—APOE—Parkinson's disease	2.62e-06	1.64e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—CASP3—Parkinson's disease	2.61e-06	1.63e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—MAPK8—Parkinson's disease	2.61e-06	1.63e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling by GPCR—IL6—Parkinson's disease	2.6e-06	1.62e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—CASP3—Parkinson's disease	2.59e-06	1.62e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling by GPCR—IL6—Parkinson's disease	2.57e-06	1.6e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—MAPK8—Parkinson's disease	2.56e-06	1.6e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—ABCB1—Parkinson's disease	2.55e-06	1.6e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—GPX1—Parkinson's disease	2.52e-06	1.57e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—MAPK8—Parkinson's disease	2.52e-06	1.57e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—INS—Parkinson's disease	2.5e-06	1.56e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—MAPK8—Parkinson's disease	2.48e-06	1.55e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—GSTM1—Parkinson's disease	2.48e-06	1.55e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—CASP3—Parkinson's disease	2.46e-06	1.54e-05	CbGpPWpGaD
Aripiprazole—HTR1E—Signaling Pathways—IL6—Parkinson's disease	2.46e-06	1.54e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—INS—Parkinson's disease	2.46e-06	1.54e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—INS—Parkinson's disease	2.45e-06	1.53e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—INS—Parkinson's disease	2.45e-06	1.53e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling by GPCR—IL6—Parkinson's disease	2.45e-06	1.53e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—INS—Parkinson's disease	2.45e-06	1.53e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—INS—Parkinson's disease	2.44e-06	1.52e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—CASP3—Parkinson's disease	2.43e-06	1.52e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling by GPCR—IL6—Parkinson's disease	2.42e-06	1.51e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—INS—Parkinson's disease	2.41e-06	1.51e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—INS—Parkinson's disease	2.41e-06	1.5e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—MAPK8—Parkinson's disease	2.4e-06	1.5e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—MAPK8—Parkinson's disease	2.38e-06	1.48e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—GPX1—Parkinson's disease	2.38e-06	1.48e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	2.34e-06	1.46e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—MTHFR—Parkinson's disease	2.33e-06	1.45e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—CTGF—Parkinson's disease	2.3e-06	1.43e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—MAPK8—Parkinson's disease	2.26e-06	1.41e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—INS—Parkinson's disease	2.24e-06	1.4e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—MAPK8—Parkinson's disease	2.23e-06	1.4e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—CASP3—Parkinson's disease	2.22e-06	1.38e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling by GPCR—IL6—Parkinson's disease	2.2e-06	1.37e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—CASP3—Parkinson's disease	2.2e-06	1.37e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—MTHFR—Parkinson's disease	2.19e-06	1.37e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling by GPCR—IL6—Parkinson's disease	2.18e-06	1.36e-05	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—IL6—Parkinson's disease	2.18e-06	1.36e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—APOE—Parkinson's disease	2.17e-06	1.35e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	2.14e-06	1.34e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—CASP3—Parkinson's disease	2.12e-06	1.32e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—NQO1—Parkinson's disease	2.12e-06	1.32e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—CASP3—Parkinson's disease	2.11e-06	1.32e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling by GPCR—IL6—Parkinson's disease	2.11e-06	1.31e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling by GPCR—IL6—Parkinson's disease	2.09e-06	1.31e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—TH—Parkinson's disease	2.09e-06	1.3e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—CASP3—Parkinson's disease	2.05e-06	1.28e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—APOE—Parkinson's disease	2.04e-06	1.27e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling by GPCR—IL6—Parkinson's disease	2.04e-06	1.27e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—MAPK8—Parkinson's disease	2.04e-06	1.27e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—CASP3—Parkinson's disease	2.02e-06	1.26e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—MAPK8—Parkinson's disease	2.02e-06	1.26e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—IL6—Parkinson's disease	2.01e-06	1.25e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—CYCS—Parkinson's disease	2e-06	1.25e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—MAPK8—Parkinson's disease	1.95e-06	1.22e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—MAPK8—Parkinson's disease	1.94e-06	1.21e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—MAPK8—Parkinson's disease	1.88e-06	1.18e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—CASP3—Parkinson's disease	1.86e-06	1.16e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—MAPK8—Parkinson's disease	1.85e-06	1.16e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—INS—Parkinson's disease	1.85e-06	1.16e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—IL6—Parkinson's disease	1.85e-06	1.15e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—CASP3—Parkinson's disease	1.83e-06	1.14e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—CASP3—Parkinson's disease	1.83e-06	1.14e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—CASP3—Parkinson's disease	1.82e-06	1.14e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—IL6—Parkinson's disease	1.82e-06	1.14e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—CASP3—Parkinson's disease	1.82e-06	1.13e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—IL6—Parkinson's disease	1.81e-06	1.13e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—IL6—Parkinson's disease	1.81e-06	1.13e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—IL6—Parkinson's disease	1.8e-06	1.13e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CASP3—Parkinson's disease	1.8e-06	1.12e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CASP3—Parkinson's disease	1.79e-06	1.12e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—IL6—Parkinson's disease	1.79e-06	1.12e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—IL6—Parkinson's disease	1.78e-06	1.11e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—COMT—Parkinson's disease	1.77e-06	1.11e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.76e-06	1.1e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.76e-06	1.1e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—INS—Parkinson's disease	1.74e-06	1.09e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.74e-06	1.09e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—MAPK8—Parkinson's disease	1.71e-06	1.07e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—MAPK8—Parkinson's disease	1.68e-06	1.05e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—IL6—Parkinson's disease	1.68e-06	1.05e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—MAPK8—Parkinson's disease	1.68e-06	1.05e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—IL6—Parkinson's disease	1.68e-06	1.05e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—MAPK8—Parkinson's disease	1.67e-06	1.05e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—ABCB1—Parkinson's disease	1.67e-06	1.04e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—MAPK8—Parkinson's disease	1.67e-06	1.04e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—IL6—Parkinson's disease	1.67e-06	1.04e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CASP3—Parkinson's disease	1.67e-06	1.04e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—IL6—Parkinson's disease	1.65e-06	1.03e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—MAPK8—Parkinson's disease	1.65e-06	1.03e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—MAPK8—Parkinson's disease	1.65e-06	1.03e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—IL6—Parkinson's disease	1.63e-06	1.02e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GSTM1—Parkinson's disease	1.62e-06	1.01e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—IL6—Parkinson's disease	1.61e-06	1e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—IL6—Parkinson's disease	1.59e-06	9.9e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GPX1—Parkinson's disease	1.55e-06	9.7e-06	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—IL6—Parkinson's disease	1.53e-06	9.58e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—MAPK8—Parkinson's disease	1.53e-06	9.56e-06	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—IL6—Parkinson's disease	1.52e-06	9.48e-06	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—IL6—Parkinson's disease	1.45e-06	9.03e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—MTHFR—Parkinson's disease	1.43e-06	8.95e-06	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—IL6—Parkinson's disease	1.43e-06	8.91e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—APOE—Parkinson's disease	1.33e-06	8.33e-06	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—IL6—Parkinson's disease	1.3e-06	8.12e-06	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—IL6—Parkinson's disease	1.29e-06	8.05e-06	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—IL6—Parkinson's disease	1.24e-06	7.77e-06	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—IL6—Parkinson's disease	1.24e-06	7.73e-06	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—IL6—Parkinson's disease	1.2e-06	7.52e-06	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—IL6—Parkinson's disease	1.18e-06	7.4e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—INS—Parkinson's disease	1.14e-06	7.12e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—IL6—Parkinson's disease	1.09e-06	6.82e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—IL6—Parkinson's disease	1.07e-06	6.71e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—IL6—Parkinson's disease	1.07e-06	6.7e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—IL6—Parkinson's disease	1.07e-06	6.67e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—IL6—Parkinson's disease	1.07e-06	6.65e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—IL6—Parkinson's disease	1.05e-06	6.59e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—IL6—Parkinson's disease	1.05e-06	6.57e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IL6—Parkinson's disease	9.78e-07	6.1e-06	CbGpPWpGaD
